Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionAlta Wealth Advisors LLC
Latest Disclosed Ownership12,468 shares
Latest Disclosed Value $ 1,737,677
Alta Wealth Advisors LLC reports 0.02% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 4, 2026 - Alta Wealth Advisors LLC filed a 13F-HR form disclosing ownership of 12,468 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,737,677 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 12,471 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.02% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F GILEAD SCIENCES COM 375558103 12,468 -3 -0.02 1,738 13.53 0.5643
2026-02-03 2025-12-31 13F GILEAD SCIENCES COM 375558103 12,471 106 0.86 1,531 11.52 0.5115
2025-11-03 2025-09-30 13F GILEAD SCIENCES COM 375558103 12,365 -74 -0.59 1,372 -0.51 0.4916
2025-07-22 2025-06-30 13F GILEAD SCIENCES COM 375558103 12,439 1 0.01 1,379 -1.01 0.6508
2025-04-24 2025-03-31 13F GILEAD SCIENCES COM 375558103 12,438 411 3.42 1,394 25.50 0.6398
2025-01-23 2024-12-31 13F GILEAD SCIENCES COM 375558103 12,027 7 0.06 1,111 10.23 0.4861
2024-10-18 2024-09-30 13F GILEAD SCIENCES COM 375558103 12,020 -19 -0.16 1,008 22.06 0.4606
2024-07-24 2024-06-30 13F GILEAD SCIENCES COM 375558103 12,039 27 0.22 826 -6.14 0.4121
2024-05-01 2024-03-31 13F GILEAD SCIENCES COM 375558103 12,012 337 2.89 880 -6.98 0.4471
2024-02-12 2023-12-31 13F GILEAD SCIENCES COM 375558103 11,675 -53 -0.45 946 7.63 0.5276
2023-10-19 2023-09-30 13F GILEAD SCIENCES COM 375558103 11,728 -148 -1.25 879 -4.04 0.5384
2023-07-17 2023-06-30 13F GILEAD SCIENCES COM 375558103 11,876 299 2.58 915 -4.69 0.5374
2023-04-21 2023-03-31 13F GILEAD SCIENCES COM 375558103 11,577 101 0.88 961 -2.54 0.6062
2023-01-20 2022-12-31 13F GILEAD SCIENCES COM 375558103 11,476 493 4.49 985 45.28 0.6656
2022-10-17 2022-09-30 13F GILEAD SCIENCES COM 375558103 10,983 850 8.39 678 8.31 0.4851
2022-07-28 2022-06-30 13F GILEAD SCIENCES COM 375558103 10,133 0 0.00 626 3.99 0.4337
2022-04-27 2022-03-31 13F GILEAD SCIENCES COM 375558103 10,133 10,133 602 0.3572
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.